Christopher J. Lafond
Analyst · Peter Appert with Piper Jaffray
Thanks, Gene, and good morning, everyone. We ended 2012 with double-digit growth in revenue, earnings and free cash flow. Our results continue to demonstrate the successful execution of our strategy and our ability to consistently deliver on the financial objectives we've communicated over the past several years. In the fourth quarter, we continued to see the strong trends in our key business metrics that we delivered during the first 3 quarters of the year. Year-over-year contract value growth remained strong, and retention rates ended at or near all-time highs. Our benchmark and core Consulting businesses grew 6% on an FX neutral basis for the full year, and our Events business increased by more than 20% year-over-year for the third consecutive year. Demand for our services was robust across all of our primary business segments in the fourth quarter. Our strong top line performance and effective execution in capitalizing on the operating leverage in our business allowed us to once again expand both our gross contribution and EBITDA margins. As a result, we delivered significant growth in earnings both in Q4 and for the full year. In the fourth quarter, normalized EBITDA increased 14% year-over-year, and our GAAP diluted earnings per share was up 33%. For the full year, we delivered normalized EBITDA of $315 million, up 13% from 2011. This growth in normalized EBITDA was notable, given that in our Consulting segment, the Contract Optimization business underperformed our expectations in 2012 and resulted in a negative impact to EBITDA of $8 million. I will talk more about this in a moment. GAAP diluted earnings per share was up 24% from last year to $1.73. With a strong finish to 2012, we're well positioned for continued growth in 2013. Now, I'll provide a review of our 3 business segments for the fourth quarter and full year, and then I'll conclude with a discussion of our outlook for 2013. Starting with Research. Fourth quarter Research revenue was up 14% to $300 million. And on an FX neutral basis, Research revenue grew 15% in the fourth quarter and 14% for the full year in 2012. The contribution margin in this segment increased 65 basis points to 67.6% in the fourth quarter as our strong execution continues to capitalize on the operating leverage in this business. For the full year, the contribution margin in our Research business grew by 70 basis points to 68.1%. All of our key Research business metrics remained very strong in the fourth quarter. Contract value grew a record level $1.263 billion, a growth rate of 14% year-over-year on FX neutral basis. As was the case throughout 2012, our growth in contract value in Q4 was extremely broad-based across all geographies, client sizes and industry segments. New business again increased year-over-year, continuing the trends we've seen since late 2009. The new business mix was balanced between sales to new clients and sales of additional services and upgrades to existing clients. While our contract value growth continues to benefit from our discipline of annual price increases and no discounting, approximately 80% of our contract value growth came from volume, with the balance coming from price increases. This volume growth reflects our success in continuing to grow the business by penetrating our vast market opportunity with both new and existing clients. As a result, we ended the quarter with 13,305 client organizations, up 7% year-over-year. As for pricing, we've consistently increased our prices by 3% to 6% by year on an annual basis since 2005. We implemented a price increase during the fourth quarter of 2012, and we expect to do so again in 2013. We should note that the average contract value per client organization has risen to another all-time high of $95,000 per organization, up from $90,000 last year. We continue to penetrate existing clients by leveraging our strong relationships. Our client retention rate ended the quarter at 83%, and we retained client retention near record highs for 10 quarters in a row. In addition to retaining our research clients at an impressive rate, the clients we retained continue to increase their spending with us. Wallet retention ended the year at 99%. Wallet retention is higher than client retention due to a combination of increased spending by retained clients and the fact that we retained a higher percentage of our larger clients. And as we've discussed in the past, our retention metrics are reported on a 4 quarter rolling basis in order to eliminate any seasonality. In summary, our Research segment continued its strong performance in the fourth quarter. We grew our contract value by $155 million on an FX neutral basis year-over-year. We continued to see high levels of demand from clients, and we expect acceleration in contract value and revenue growth over time. We remain confident in our ability to deliver double-digit annual revenue growth in this business over the long term. Moving on to Consulting. Revenue in our Consulting business declined 8% on a reported basis in the fourth quarter. Excluding the impact from foreign exchange, Consulting revenue declined 7%. For the full year, Consulting revenue declined 1% to $305 million but grew 1%, excluding foreign exchange. While the segment results were below our expectations, our benchmark and core Consulting businesses grew 6%, excluding foreign exchange in 2012. This is towards the high end of our long-term financial objectives for this segment. Backlog, the key leading indicator of future revenue growth for our Consulting business, ended the quarter at $103 million, which represents 2% growth year-over-year and a healthy 4 months of backlog. Additionally, our pipeline looks equally solid as we begin 2013. Billable headcount of 503 was up 5% from the fourth quarter of 2011. This reflects our focus on matching resources to the demand we saw in our labor-based Consulting business during 2012. Fourth quarter utilization was over 67%, up 330 basis points from the prior quarter, and revenue per billable headcount ended the quarter at $445,000. Excluding the Contract Optimization business, the overall Consulting segment had a very strong 2012. So let me spend a moment on Contract Optimization. As we told you in the past, this part of our Consulting segment can fluctuate from quarter-to-quarter and year-to-year. And to put this business in perspective for you, Contract Optimization represents only 10% of our Consulting segment and continues to decline as a percentage of Consulting and total company revenue each year. We expect Contract Optimization revenue to range from approximately $30 million to $40 million annually. It ended 2012 at the low end of that range after ending slightly above $40 million in 2011. While this impacted our overall Consulting results in 2012, we expect the overall Consulting segment to grow in the range of our long-term financial objectives in 2013. Turning now to Events. Events in the fourth quarter increased 21% year-over-year on a reported basis and 24%, excluding the impact of foreign exchange. During the fourth quarter, we held 14 events with 22,540 attendees compared to 12 events with 20,500 attendees in the fourth quarter of 2011. Total attendees of our events during Q4 on a same events basis were up 5% year-over-year and exhibitors were up 21%. For the full year, revenue for our Events business increased 20% year-over-year on an FX neutral basis. At the 62 events held in 2012 versus the 60 held in 2011, attendees were up 8%, exhibitors were up 20% year-over-year. On a same Events basis, attendees were up 7% and exhibitors were up 18%. For the full year 2012, the events gross contribution margin was 46%, up 148 basis points from 2011. Moving down the income statement. During the fourth quarter, our total gross contribution margin was 59% compared to 58% in the prior year. And for the full year, our total gross contribution margin increased 86 basis points to 60%. These increases were primarily due to the successful execution of our strategy to capitalize on the high incremental margins and operating leverage inherent in our Research business. SG&A increased by $15 million year-over-year during the fourth quarter. We continue to tightly control G&A costs across the entire company, and we continue to believe that this expense item will provide us with the source of operating leverage in the future as G&A will continue to decline as a percent of revenue. The SG&A increase is driven by the growth of our sales force. And as of December 31, we have 1,417 quota-bearing sales associates as compared to 1,268 a year ago. For the full year, we added 149 salespeople, constituting 12% growth and slightly below our long-term target of growing our sales force by 15% to 20% per year. As we told you in the past, we will always be thoughtful about the expansion of our sales organization. When the sales productivity remained flat in the back half of 2012, we slowed the pace of hiring in order to improve productivity. As Gene mentioned, we're focused on increasing sales productivity and, as we've been consistently told you, intend to grow our sales force by 15% to 20% annually. Sales force growth in 2012 should not be construed as a change in our growth expectations. We remain confident both in our market opportunity and growth expectations. Moving on to earnings. We delivered another strong quarter of solid earnings growth. Normalized EBITDA was $97 million in the fourth quarter, up 14% year-over-year. And GAAP diluted earnings per share was $0.61, up 33% year-over-year. Our normalized EBITDA margin increased 60 basis points to 20.4%. And as expected, our Q4 2012 GAAP diluted earnings per share includes $0.02 in amortization and other costs associated with our acquisitions, including Ideas International. This trend continues to reflect our commitment to improving margins while also investing in the growth of our business. For the full year, normalized EBITDA was $315 million, up 13% year-over-year. And GAAP diluted earnings per share was $1.73, up 24% year-over-year. Our normalized EBITDA margin increased 50 basis points to 19.5%. And as I mentioned previously, our earnings were adversely impacted by a shortfall in our Contract Optimization business. EPS was positively impacted by a lower than expected tax rate in the fourth quarter and for the full year, largely due to the release of tax reserves related to the close of tax audits. And also diluted EPS for the full year 2012 included acquisition-related charges of $0.05 per share compared to $0.04 per share in 2011. Turning to cash. Our strong performance for the full year translated into continued growth in free cash flow, which increased by 11% to $237 million. Over the long term, we continue to expect to generate free cash flow substantially greater than our net income, given our tight cash management and the negative working capital characteristics of our Research business. During the fourth quarter, we utilized our cash to return capital to shareholders through our share repurchase program, and we repurchased almost 480,000 shares at a total cost of approximately $22 million. For the full year, we repurchased 2.7 million shares at a total cost of $111 million. We ended the quarter with a strong balance sheet and cash position with net cash of $95 million. Our current credit facility runs through December of 2015 and, at this time, provides us with almost $350 million of remaining borrowing capacity. We have ample cash flow and liquidity to continue to grow our business and execute initiatives that drive increased shareholder value. We continue to look for attractive acquisition opportunities as a potential use of cash. And in absence of appropriate acquisition opportunities, we believe that repurchasing our shares remains a compelling use of our capital and we have $210 million remaining under our board authorization. Let me now turn to our business outlook for 2013. Based on the strong business trends we experienced in 2012, we believe our businesses are well positioned for another year of strong growth. Our guidance for 2013 is based on the following assumptions: the current macroeconomic environment continues throughout the year, revenues of the Contract Optimization business and our Consulting segment remain at 2012 levels, sales productivity remains at 2012 levels, our sales force grows approximately 15%. And with regard to foreign exchange, our guidance is based on the spot rates in early January. We've made no attempt in our guidance to anticipate any strengthening or weakening of the U.S. dollar from the actual foreign-exchange rates in early January. In light of the current macro-environment, we believe this are prudent assumptions. And so for the full year 2013, we expect total revenues will grow by 10% to 13%, to approximately $1.78 billion to $1.82 billion on a reported basis. Projected revenues by segment can be found in our press release. But I would note that we expect growth at each of our 3 segments during 2013, with Research revenue expected to be up 13% to 14%, Consulting revenue up 2% to 7% and Events revenue up 6% to 12%. Moving down to income statement. We expect normalized EBITDA for the full year 2013 to be between $350 million and $370 million, an increase of 11% to 17% over 2012. In 2013, we expect the cost associated with stock-based compensation expense to be approximately $37 million to $38 million. Total depreciation and amortization should be approximately $33 million to $34 million, inclusive of the amortization of acquisition intangible assets. We expect interest expense of approximately $10 million, other expense of approximately $2 million. We're projecting an annual effective tax rate of approximately 31%, and our guidance is based on an average fully diluted shares outstanding of approximately 95 million shares for the year. Note that our tax rate may vary from quarter-to-quarter due to the timing of certain items. Our GAAP earnings guidance for 2013 is for EPS to be between $1.96 and $2.10 per share. The intangible amortization associated with the acquisitions of AMR, Burton and Ideas will equate to approximately $0.04 per share for 2013. And as a result, we expect our EPS, excluding amortization from acquisitions, to be between $2 and $2.14 per share. We also expect to grow free cash flow as we drive growth in our Research business. In 2013, we expect cash from operations of $296 million to $316 million, capital expenditures of $37 million to $38 million and free cash flow of $259 million to $278 million. Thus, we expect to grow our free cash flow by 10% to 17% in 2013 and generate free cash flow per share of $2.73 to $2.94, substantially above our income per share. I'd like to note that cash from operations includes $3 million to be received as a tenant improvement allowance in connection with the previously disclosed lease arrangement on our Stamford headquarters. And the $3 million in the related costs of these improvements are reflected on our capital expenditures despite being reimbursed by the landlord. These amounts are not expected to have any impact on free cash flow during the life of the renovation project, which should end in early 2013 and is not expected to recur. While our policy is to provide annual but not quarterly guidance, I'd like to provide some additional information to allow for an understanding of the seasonality and other factors that will impact our revenue and earnings on a quarterly basis. In 2013, total revenue, segment revenue and EPS phasing by quarter will approximate our reported results from 2012. I would also point out that the first quarter will again be the seasonally lightest quarter, with EPS coming in at less than 20% of the full year EPS. I would also like to remind you that our Events segment is highly seasonal and more than 50% of the full year revenue to be recognized in Q4 because our Fall Symposium series is held at that quarter. At this point, we plan to host between 64 and 67 events in 2013 as compared to 62 in 2012. Finally, I'd like to spend a moment on the impact of foreign exchange as it relates to our reported contract value. As we've communicated to you in the past, research contract value is reported on an FX neutral basis throughout each year. We do this so you can understand the true organic growth in our Research segment. In January of each year, we restate the opening contract value at current foreign-exchange rates. As a result of changes in FX rates since January of 2012, contract value on January 1, 2013, is approximately $7 million higher than the $1,263,000,000 reported on December 31. And as a result, $1,270,000,000 is the baseline figure you should use for comparison purposes when analyzing FX neutral contract value growth in 2013. So to summarize, we delivered great results both for the fourth quarter and full year 2012. Demand for our services is strong. And as a result, we generated double-digit revenue growth, and our key business metrics remained strong throughout 2012. Our initiatives to improve operational effectiveness, coupled with the operating -- positive operating leverage inherent in our businesses, delivered strong margin expansion, and we generated substantial cash flow. As always, we're actively exploring strategic alternatives for deploying our cash. We'll continue to invest in our business and return capital to shareholders through our share repurchase program, and we expect to repurchase shares throughout 2013. Finally, with double-digit growth in contract value in 2012, we established a solid foundation for delivering another strong year of revenue and earnings growth in 2013. We're well positioned for double-digit revenue and earnings growth and increasing returns to our shareholders over the long-term. We'll now be happy to take your questions. Operator?